Welcome to Flow Pharma Inc.

Page Loading...

Menu
blob-1
blob-2
Our Bio-Medicines

FlowVax HPV

Flow Pharma is developing FlowVax HPV to treat cervical and throat cancers. HPV causes nearly all cervical cancers, as well as most head and neck cancers.


Overview

  • Under Development, FDA Approval Required.
  • HPV is the cause in virtually all cervical cancers and most head and neck squamous cell cancers.
  • Our therapeutic T-cell vaccine for cervical and head & neck cancer targets the HPV16 E6 and E7 Oncoproteins.
  • It is delivered by intranodal injection.

Status

  • Pre-Clinical Feasibility
  • Phase I

What is HPV?

HPV-infected koilocytes

Human papillomavirus (HPV) cases Human papillomavirus infection (HPV infection). It is a DNA virus from the Papillomaviridae family. About 90% of HPV infections cause no symptoms and resolve spontaneously within two years. However, in some cases, an HPV infection persists and results in either warts or precancerous lesions. These lesions, depending on the site affected, increase the risk of cancer of the cervix, vulva, vagina, penis, anus, mouth, or throat. Nearly all cervical cancer is due to HPV

A group of HPV-infected koilocytes on the the bottom right is accompanied by two normal intermediate squamous cells at the top and left. Credit: Ed Uthman

Read More.


Want to learn more about the science behind the solution?

View Resources